Name-based reporting of HIV-positive test results as a deterrent to testing.
- 1 July 1999
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 89 (7) , 1097-1100
- https://doi.org/10.2105/ajph.89.7.1097
Abstract
OBJECTIVES: This study evaluated attitudes toward name-based reporting of HIV. METHODS: One hundred thirty high-risk, male repeat testers received information on the public health benefits of name-based reporting and reported their intentions to test. RESULTS: Of the 67 men who were randomly selected and asked their intentions before hearing the benefits, 63% said they would not test if reporting were required. After hearing the benefits, 19% changed their minds (P < .014). Of the 63 men who were asked only after hearing the benefits, 44% would not test. CONCLUSIONS: Implementing name-based reporting without working before-hand to change attitudes could undermine the benefits of both testing and HIV surveillance.Keywords
This publication has 18 references indexed in Scilit:
- Health benefits and risks of reporting HIV-infected individuals by name.American Journal of Public Health, 1998
- National HIV Case Reporting for the United States — A Defining Moment in the History of the EpidemicNew England Journal of Medicine, 1997
- Monitoring current HIV transmission to promote preventionAIDS, 1995
- Annotation: what will be the role of HIV infection reporting?American Journal of Public Health, 1994
- Public Health Policy and the AIDS EpidemicNew England Journal of Medicine, 1991
- A Dual Approach to the AIDS EpidemicNew England Journal of Medicine, 1991
- Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior.Psychological Bulletin, 1990
- Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being testedPublished by American Medical Association (AMA) ,1989
- Validity of Self‐reported Alcohol Use: a literature review and assessment*British Journal of Addiction, 1988
- TRIAL OF ANONYMOUS VERSUS CONFIDENTIAL HUMAN IMMUNODEFICIENCY VIRUS TESTINGThe Lancet, 1988